Elekta AB (publ) (OTCMKTS:EKTAY – Get Rating) shares passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $7.09 and traded as low as $7.04. Elekta AB (publ) shares last traded at $7.14, with a volume of 24,032 shares changing hands.
Wall Street Analyst Weigh In
Separately, JPMorgan Chase & Co. dropped their price target on Elekta AB (publ) from SEK 79 to SEK 69 and set an “underweight” rating on the stock in a research note on Tuesday, April 26th.
Elekta AB (publ) Price Performance
The company has a quick ratio of 0.95, a current ratio of 1.17 and a debt-to-equity ratio of 0.52. The business has a 50-day moving average price of $7.09 and a two-hundred day moving average price of $7.83. The company has a market capitalization of $2.74 billion, a price-to-earnings ratio of 20.99 and a beta of 1.01.
Elekta AB (publ) Company Profile
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology.
Further Reading
- Get a free copy of the StockNews.com research report on Elekta AB (publ) (EKTAY)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
- Why Apple Could Be At All-Time Highs By Year End
Receive News & Ratings for Elekta AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elekta AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.